[Factors associated with mortality due to SARS-CoV-2 in the population over 75 years of age in the Community of Madrid].

Factores asociados con la mortalidad por SARS-CoV-2 en la población mayor de 75 años de la Comunidad de Madrid.
Aged COVID-19 Mortality Risk factors SARS-CoV-2

Journal

Revista clinica espanola
ISSN: 1578-1860
Titre abrégé: Rev Clin Esp
Pays: Spain
ID NLM: 8608576

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 20 02 2022
accepted: 04 06 2022
pubmed: 21 6 2022
medline: 21 6 2022
entrez: 20 6 2022
Statut: ppublish

Résumé

Various studies have identified factors associated with risk of mortality in patients with SARS-CoV-2 infection. However, their sample size has often been limited and their results partially contradictory. This study evaluated factors associated with COVID-19 mortality in the population of Madrid over 75 years of age, in infected patients, and in hospitalized patients up to January 2021. This population-based cohort study analyzed all residents of the Community of Madrid born before January 1, 1945 who were alive as of December 31, 2019. Demographic and clinical data were obtained from primary care electronic medical records (PC-Madrid), data on hospital admissions from the A total of 587,603 subjects were included in the cohort. Of them, 41,603 (7.1%) had confirmed SARS-CoV-2 infection, of which 22,362 (53.7% of the infected individuals) were hospitalized and 11,251 (27%) died. Male sex and age were the factors most closely associated with mortality, though many comorbidities also had an influence. The associations were stronger in the analysis of the total population than in the analysis of infected or hospitalized patients. Mortality among hospitalized patients was lower during the second wave (33.4%) than during the first wave (41.2%) of the pandemic. Age, sex, and numerous comorbidities are associated with risk of death due to COVID-19. Mortality in hospitalized patients declined notably after the first wave of the pandemic.

Identifiants

pubmed: 35720162
doi: 10.1016/j.rce.2022.06.002
pii: S0014-2565(22)00082-0
pmc: PMC9193184
doi:

Types de publication

English Abstract Journal Article

Langues

spa

Pagination

468-478

Informations de copyright

© 2022 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Références

Lancet Rheumatol. 2021 Jul;3(7):e498-e506
pubmed: 33997800
Lancet. 2021 Sep 4;398(10303):843-855
pubmed: 34388395
Clin Microbiol Infect. 2021 Aug;27(8):1158-1166
pubmed: 33915287
Euro Surveill. 2021 May;26(20):
pubmed: 34018483
BMJ Open. 2019 Sep 20;9(9):e030344
pubmed: 31542750
Gac Sanit. 2021 Mar-Apr;35(2):113-122
pubmed: 32014314
Arch Gerontol Geriatr. 2020 Jul 27;91:104204
pubmed: 32771883
Chronic Obstr Pulm Dis. 2021 Oct 28;8(4):517-527
pubmed: 34614553
Tuberc Respir Dis (Seoul). 2022 Jan;85(1):74-79
pubmed: 34775736
PLoS One. 2021 Nov 12;16(11):e0259822
pubmed: 34767594
Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):172-180
pubmed: 33107909
BMJ Open. 2020 Nov 19;10(11):e040402
pubmed: 33444201
Int J Epidemiol. 2021 Mar 3;50(1):64-74
pubmed: 33349845
Lancet Respir Med. 2020 May;8(5):436-438
pubmed: 32251625
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e28-e37
pubmed: 33103720
BMC Med Res Methodol. 2011 Oct 28;11:146
pubmed: 22035202
BMJ. 2020 Nov 27;371:m4509
pubmed: 33246972
PLoS One. 2021 Oct 5;16(10):e0258154
pubmed: 34610047
Atherosclerosis. 2022 Jan;341:13-19
pubmed: 34959204
Respir Med. 2021 Nov-Dec;189:106640
pubmed: 34627008
Virol J. 2022 May 15;19(1):84
pubmed: 35570298

Auteurs

J M Mostaza (JM)

Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, España.

M A Salinero-Fort (MA)

Fundación de Investigación Biosanitaria y de Innovación de Atención Primaria (FIIBAP), Instituto de Investigación del Hospital La Paz (IdIPAZ); Red de Investigación en pacientes crónicos (REDISSEC); Subdirección general de Investigación en Salud, Ministerio de Sanidad, Madrid, España.

J Cardenas-Valladolid (J)

Dirección Técnica de Sistemas de Información Sanitaria, Gerencia Adjunta de Procesos Asistenciales, Gerencia Asistencial de Atención Primaria, Madrid, España.

F Rodríguez-Artalejo (F)

Departamento de Medicina Preventiva y Salud Pública, Universidad Autónoma de Madrid-IdIPAZ, CIBER de Epidemiología y Salud Pública (CIBERESP) e IMDEA-Alimentación, CEI UAM + CSIC, Madrid, España.

M Díaz-Almirón (M)

Unidad de Investigación, Instituto de Investigación Hospital La Paz, IdiPAZ, Madrid, España.

P Vich-Pérez (P)

Fundación de Investigación Biosanitaria y de Innovación de Atención Primaria (FIIBAP), Centro de Salud Los Alpes, Madrid, España.

F J San Andrés-Rebollo (FJ)

Fundación de Investigación Biosanitaria y de Innovación de Atención Primaria (FIIBAP), Centro de Salud Las Calesas, Madrid, España.

I Vicente (I)

Centro de Salud Monovar, Madrid, España.

C Lahoz (C)

Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, España.

Classifications MeSH